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ABSTRACT 
INTRODUCTION: 
Obstructive jaundice or surgical jaundice or extrahepatic cholestatic jaundice 
occurs due to obstruction to the outflow of bile.It can be intrahepatic or 
extrahepatic obstruction.The disease has a high morbidity and mortality rates. 
OBJECTIVES: 
This study was done to analyse the etiological spectrum of obstructive jaundice,the 
clinical presentation, relevance of  the available investigations and management for 
benign and malignant jaundice in our set up. 
METHODS: 
In my study I have included 50 patients who were diagnosed to have obstructive 
jaundice and were receiving treatment in Tirunelveli Medical College Hospital.All 
of them were investigated biochemically and radiologically and managed 
appropriately. 
RESULTS: 
In this study male:female incidence of the disease was found to be 1.3:1 indicating 
the high prevalence in males.The most commonly affected age group was 50-60 
years with the mean age of 52.5 years.Malignant disease was found to be more 
common in elderly males.About 54% presented with yellowish discoloration of the 
skin and sclera as the chief complaint and about 70% cases had malignant 
etiology.The most common benign etiology was found to be choledocholithiasis 
and the most common malignancy was found to be periampullary carcinoma.The 
most common morbidity due to the disease was cachexia.Ultrasound abdomen 
confirmed the presence of biliary obstruction in all cases and CT abdomen 
identified the etiology in almost all cases.50% of the cases were treated with 
surgery and 32% received palliative treatment in the form of chemotherapy and 
radiotherapy and ascetic fluid tapping. 
CONCLUSION: 
Malignant jaundice occurs most commonly in elderly males.Periampullary 
carcinoma is the most common malignant etiology in our set up.USG and CT 
abdomen are valuable investigations in confirming the diagnosis and detection of 
the etiology.3 patients died showing a mortality rate of 6% in this study.Early 
diagnosis and treatment plays an important role in the prognosis of the patients 
with obstructive jaundice. 
KEYWORDS: 
Obstructive jaundice,etiology,malignant jaundice,palliation. 
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INTRODUCTION 
The word “jaundice” arises from the French word jaune, which means 
yellow. Jaundice is defined as yellowish discoloration of the skin, sclera, and 
the mucous membranes by bilirubin, a yellow-orange bile pigment. Bilirubin 
is formed as a catabolic product of heme rings, usually due to metabolism of  
red blood cells. The discoloration is   identified clinically once the serum 
bilirubin level rises above 3 mg per dL (51.3 μmol per L). 
Jaundice is a most common problem in both medical and surgical 
practice. Its etiology can often be correctly detected clinically but usually 
biochemical and radiological imaging investigations are required for 
confirmation. It could be because of a variety of etiologies and is broadly 
divided into obstructive or surgical  and non obstructive  or medical  
jaundice.  
Obstructive jaundice is jaundice due to intra or extrahepatic organic 
obstruction to biliary  outflow.It can cause  problems with the diagnosis and 
management.  
The obstruction can be caused by the blockage of the bile duct due to  
benign conditions like gall stones, strictures, choledochal cysts  and 
malignancies like carcinoma gall bladder, cholangiocarcinoma  ,carcinoma 
head of pancreas  and  periampullary carcinoma. Various rare etiologies like  
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Caroli’s syndrome ;porta hepatis nodes and primary and metastatic liver 
tumors have also been reported. 
This study is an etiopathological analysis of various causes of 
obstructive jaundice in our hospital and morbidity and mortality due to the 
disease. It also emphasizes on the surgical management that could improve 
survival of patients admitted in our hospital with jaundice. 
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AIMS OF THE STUDY 
 
The aim of this study is to  
  1) Clinically evaluate patients of obstructive jaundice .Patients with 
surgical jaundice are evaluated clinically ,biochemically and radiologically 
and the most common age incidence, sex incidence, chief complaints are 
analysed in our set up. 
           2) To asses the morbidity and mortality of the disease. 
            3)Further the sensitivity and accuracy of radiological investigations 
like ultrasonography and CT abdomen are  evaluated. 
            4) The types of treatment available and the efficacy of the different 
modalities and complications of the treatment in our hospital are analysed. 
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REVIEW OF LITERATURE 
 
                              ANATOMY OF BILIARY TREE 
 
 LIVER: 
                             Liver is a wedge shaped organ with five surfaces- anterior, 
posterior, superior, inferior and right. It is divided into right and left lobes 
anatomically and functionally. Anatomic  division is by the attachment of 
falciform ligament, ligamentum teres and ligamentum venosum. Depending 
on  the intrahepatic distribution of hepatic artery, portal vein and biliary 
ducts liver is  divided into functional right and left lobes. 
 
Figure 1:Anterior and superior  surface of the liver . 
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Figure 2:Posterior surface of the  liver. 
 
COUINAUD HEPATIC DIVISIONS
[16]
:According to Couinaud, liver 
is divided into eight segments which are  numbered in the counterclockwise 
direction by the  fissures-main portal fissure, right portal fissure and left 
portal fissure. 
BILIARY DRAINAGE
[17]
:The common bile duct is formed by the 
union of right  and left hepatic ducts.The left hepatic duct is formed by the 
joining  of three segmental ducts draining  segments II to IV.The right 
hepatic duct is formed by the joining  of right anterior  and right posterior 
segmental ducts. 
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Figure 3:Segments of the liver. 
The right posterior segmental duct is formed due to the union of ducts 
draining segments VI and VII. The right anterior segmental duct is formed 
due to the union of ducts draining segments V and VIII. n approximately 
80% of cases caudate lobe is drained by both right and left hepatic ducts. In 
15% cases it drains into only the  left hepatic duct. In 5% cases it entirely 
drains into right hepatic duct. 
VASCULAR SUPPLY
[16]
:The liver is supplied by the hepatic artery and the 
portal vein. Hepatic artery supplies one-fourth of blood supply to the liver  
and remainder is by the portal vein
[16]
.Blood from both hepatic artery and 
portal vein is  mixed  in the blood sinusoids in the liver parenchyma and 
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drained by the tributaries of the hepatic veins. Hepatic veins drain into the 
inferior vena cava. 
GALL BLABBER: 
The gall bladder lies adherent to the inferior  surface of the liver in the fossa 
for gall bladder in the junction of right and quadrate lobes. It is about 7 to 10 
cm in length
[18]
.It’s capacity is 50 to 60 ml when moderately distended. 
PARTS OF GALL BLADDER: Gall bladder has four parts-fundus, body, 
infundibulum and neck. The Hartmann’s pouch is an asymmetrical bulge 
seen in the infundibulum. The neck continues as the cystic duct. 
Spiral valves of heister are spirally arranged mucosal folds found in 
the neck and cystic duct. These  spiral valves prevent the transit of 
gallstones.  
 
Figure 4:Anatomy of the biliary tree.  
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CYSTIC DUCT : The cystic duct is about 2 to 4 cm in length. It joins the 
supraduodenal portion of the common hepatic duct(CHD) at an acute 
angle.Rarely it can join the right hepatic duct or  retroduodenal portion of 
CHD or CHD at right angles or directly enter the duodenum. 
CALOT’S TRIANGLE:Calot’s triangle is a triangular area which is very 
important during cholecystectomy. 
 
 
 
 
 
 
Figure 5:Calot’s triangle 
BOUNDARIES
[18]
-Superiorly-inferior border of right lobe of liver 
Medially-common hepatic duct  
Laterally-cystic duct. 
It contains cystic artery,right hepatic artery and  
cystic duct lymph node of Lund. 
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HISTOLOGY OF GALL BLADDER: The wall of gallbladder consists of 
five layers -the epithelium, lamina propria, smooth muscle, perimuscular 
subserosal connective tissue, and serosa. Muscularis mucosa and  submucosa 
are absent in the gall bladder. The cells in the mucosa are columnar cells, 
and their main function is absorption.  
There are invaginations of epithelium into the lamina propria, muscle, 
and subserosal connective tissue called Rokitansky-Aschoff sinuses 
[17]
. They 
are present in about 40% of the normal gallbladders and are present in large 
numbers  in all the inflamed gallbladders.  
There are very tiny bile ducts found around the muscle layer on the 
hepatic side of the gallbladder called the ducts of luschka
[17]
.They  are found 
in about 10% of normal gallbladders 
VASCULAR SUPPLY : Cystic artery is the main source of blood supply to 
gall bladder and cystic duct.It is a branch of right hepatic artery. Rarely it 
can arise from proper hepatic artery or gastroduodenal artery. An accessory 
cystic artery can arise from common hepatic artery. 
COMMON BILE DUCT(CBD):
[16]
CBD is formed by the union of cystic 
duct with the common hepatic duct which is formed by the union of right 
and left hepatic ducts.It is about 5 to 15 cm in length
[16]
. 
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It has four segments 
or parts :  
supraduodenal, 
retroduodenal, 
pancreatic and  
intramuralparts.                                                                          
as depicted in the picture.   Figure 6:Parts of common bile duct                                                                                         
SPHICTER OF ODDI
[20]
:The terminal portion of common bile duct is 
surrounded by a  ring of smooth muscles which form the sphincter 
choledochus.It’s function is to cause accumulation of bile in the gall bladder 
and concentration of bile. 
The terminal region of pancreatic duct is also surrounded by a similar 
smooth muscle ring  which forms  sphincter pancreaticus.The 
hepatopancreatic ampulla is surrounded by the third sphincter called the 
sphincter ampullae. 
Sphincter of oddi is the term applied to all sphincters collectively but more 
specifically to sphincter ampullae. 
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VASCULAR SUPPLY:Extrahepatic biliary ducts are supplied by the cystic 
artery from above and posterior superior pancreaticoduodenal artery from 
below. 
LYMPHATIC DRAINAGE: The lymphatics from gall bladder and cystic 
duct drain into cystic lymph node of lund located at the junction of cystic 
duct and common hepatic duct.From the cystic node into the hepatic nodes 
and ultimately into celiac nodes.Lymphatics from the upper bile duct drains 
into hepatic nodes.Lymphatics from the lower bile duct drain into lower 
hepatic and upper pancreatic nodes. 
NEURAL INNERVATION : Sympathetic and parasympathetic nerve supply 
to the gall bladder and biliary system is from the celiac plexus. The hepatic 
branch which arises from the anterior or left  vagus supplies the liver, gall  
bladder and bile duct. Sympathetic innervations are from 5
th
 to 9
th
 thoracic 
segments. Sensory fibres from the right phrenic nerve also innervate the gall 
bladder. This brings out the etiology for referred pain in the shoulder in any 
gall bladder disease
[17]
. 
PHYSIOLOGY OF BILIARY DRAINAGE 
BILE: 
Liver produces about 500 to 1000ml of bile per day. The secretion of 
bile is dependant on neurogenic, chemical and humoral stimuli
[19
. Vagal 
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stimulation causes  increase in secretion of bile, whereas splanchnic nerve 
stimulation causes decrease in  bile flow.Secretin is a hormone which  
increases the production and flow of bile.Other gastrointestinal hormones 
like cholecystokynin and gastrin also stimulate biliary ductular secretion. 
COMPOSITION: water, bile salts, electrolytes, bile pigments, proteins , and 
lipids. Sodium, potassium,calcium, and chlorine are in the same 
concentration in bile as in plasma. The hepatic bile is found to be neutral or 
slightly alkaline in pH, but pH can vary with diet; increase in protein diet 
shifts the pH of bile to a more acidic pH
[19]. 
Cholesterol and phospholipids are the important lipids found in bile 
and they are synthesised in liver.Their synthesis is regulated by bile salts. 
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ENTEROHEPATIC CIRCULATION:  
            Primary bile salts are synthesised in the liver from cholesterol.They 
are cholate and chenodeoxycholate.These primary bile salts are conjugated 
with taurine and glycine to produce bile acids which are anions and these 
anions are balanced by sodium in the bile.The bile salts are secreted into bile 
duct by the liver cells.They cause digestion and absorption of fatty acids and 
fat soluble vitamins in the intestine.In the terminal ileum about 80% of 
conjugated bile acids are reabsorbed.Rest are deconjugated in the gut by 
bacteria in gut to produce secondary bile acids which are deoxycholate and 
lithocholate.They are reabsorbed from the colon and returned to liver,further 
conjugated and secreted in bile.Only 5% of bile acids  is excreted in 
stool.About 95% of  bile acid pool is reabsorbed and returned back  to the 
liver called enterohepatic circulation
[19]
. 
 
Figure 7:Entero Hepatic Circulation 
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FUNCTIONS OF LIVER: 
 Protein metabolism – synthesis of plasma protein( albumin & α-acid 
glycoprotein, C-reactive protein, haptaglobin, pseudocholinesterase, 
deamination of aminoacids , formation of urea. 
 Glucose Homeostasis - gluconeogenesis, glycogenolysis (glucagon),  
glycogenesis (Insulin)  
 Fat Metabolism - Synthesis of lipoproteins, cholesterol, triglycerides,  
oxidation of fattyacid to ketone bodies 
 Reservoir of Blood 
 Endocrine Function: IGF1, Thrombopoeitin, Angiotensinogen, 
Thyroid homeostasis, steroid hormone 
inactivation(Tetosterone,estradiol,glucocorticoids,aldosterone) 
  Bilirubin formation & excretion 
 Drug & Hormone Metabolism  
 Hematological function – haematopoiesis in fetus, heme synthesis,  
 Immunological function – largest ReticuloEndothelial  organ, Kupffer 
cells - phagocytosis of  Antigen from GIT.  
 Synthesis of Coagulation factors:I,II,V,VII,IX, X,XI, XII,XIII, 
prekallikrenin,kininogen- Anticoagulants: Antithrombin III, 
α1antitrypsin, α2 antiplasmin,protein C & S, plasminogen, 
plasminogen activator inhibitor . 
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FUNCTIONS OF GALL BLADDER: 
ABSORPTION AND SECRETION: The gall bladder stores 80% of 
bile produced by the liver. The mucosa of gall the bladder has the highest 
absorptive capacity per unit surface area. It can absorb  sodium, chloride, 
bicarbonate ions and water. Bile is concentrated to over 10 fold. Rest is 
absorbed by simple diffusion. The epithelial cells secrete hydrogen ions and 
glycoproteins into the lumen. Calcium and carbonate ions are present in the 
bile. Hydrogen ions usually combine with carbonate to produce bicarbonate 
ions. Precipitation of calcium carbonate is thus prevented. Acidification 
decreases the pH of entering hepatic bile. 
NEUROHUMORAL AND MOTOR ACTIVITY: Gall bladder filling is 
regulated due to the pressure gradients between the gall bladder and bile 
ducts. It partially empties into the duodenum in association with migratory 
myenteric motor complex in the gut. 
Contraction of the gall bladder is stimulated by cholecystokynin(CCK) 
and the vagus. Splanchnic sympathetic stimulation, somatostatin and its 
analogues, vasoactive intestinal peptide, inhibits contraction and hence cause  
relaxation of gall bladder. 
SPHINCTER OF ODDI:
[19]
It creates a high pressure zone between the bile 
duct and duodenum.It regulates flow of bile and pancreatic juice into the 
duodenum and prevents the reflux of duodenal contents.It is about 4 to 6 mm 
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long and has a resting pressure of about 13mmHg higher than the duodenal 
pressure.  
BILIRUBIN METABOLISM: 
SERUM BILIRUBIN: 
 A break down product of porphyrin ring of heme – containing proteins 
which is found in blood in 2 fractions – conjugated and unconjugated 
 Conjugated fraction is water soluble and so excreted by kidneys  
 Unconjugated fraction  insoluble in water  and  bound to albumin in 
blood 
 About 300 mg of bilirubin is formed per day 
 Normal total serum bilirubin: 0.3 – 1.3 mg/dl 
 Normal value of  Direct/conjugated bilirubin is  0.1 – 0.4 mg/dl 
 Normal value of  Indirect/unconjugated bilirubin is  0.2 – 0.9mg/dl 
 When Plasma bilirubin exceeds 1mg/dl –it is called  
hyperbilirubinemia  
 Between 1-2 mg/dl –it is latent jaundice 
 >2 mg/dl – yellowish discolouration of sclera, conjunctiva, skin , 
mucous membrane occurs resulting in jaundice. 
 Senescent RBC – breaks into Hemoglobin; iron  is liberated from 
heme. 
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 Porphyrin ring breaks  down in the ReticuloEndothelial cells of liver, 
spleen ,bonemarrow to bile pigments mainly bilirubin. 
 From 6g of Hb broken down  per day – 250mg of bilirubin is formed . 
From Myoglobin & other heme containing proteins – 50 mg bilirubin 
– total 300 mg  per day. 
 In ReticuloEndothelial cells haemoglobin splits into – heme + 
globin(heme oxygenase) –   biliverdin +CO+ Iron ---  bilirubin ( 
biliverdin reductase ) 
 In liver – bilirubin formed in ReticuloEndothelial  cells is insoluble in 
water – so , lipophilic bilirubin is transported in plasma bound to 
albumin. 
 1 molecule of albumin combines  with  2 molecule of  bilirubin  
 Albumin – bilirubin complex  reach the sinusoidal surface of liver – 
bilirubin is taken up by carrier  active process. 
 Conjugation in liver – With glucuronic acid , to make it water soluble 
– bilirubin diglucuronide  by the enzyme UDP – glucuronyl 
transferase . 
 Excretion of bilirubin – Water soluble conjugated bilirubin is excreted 
into bile  by active process against concentration gradient which is the  
rate limiting step in catabolism of Heme. 
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 Fate of conjugated bilirubin –It  reaches intestine through bile. 
Intestinal bacteria deconjugate it ---its’ further reduced to 
urobilinogen. 
 20% Urobilinogen is in  enterohepatic circulation 
 Since, Urobilinogen is passed through blood , a small fraction is 
excreted in urine < 4mg/dl 
 Further ---- mesobilinogen and stercobilinogen  are formed. 
 Stercobilinogen – is excreted through faeces (200-300mg/day) 
 Urobilinogen and Stercobilinogen are oxidized to  --- Urobilin , 
stercobilin  
 Urobilin,stercobilin –are excreted in  urine and  faeces. 
Table 1:Differences 
between unconjugated and conjugated bilirubin: 
UNCONJUGATED         CONJUGATED 
In water insoluble soluble 
In alcohol soluble soluble 
Normal value 0.2-0.9mg/dl 0.1-0.4mg/dl 
In bile Its Absent Its Present 
In urine  Always absent Normally absent 
Absorption in 
gut 
Absorbed Not absorbed 
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Diffusion into 
tissues 
Diffuses and 
produces  yellow 
colour 
Doesn’t diffuse 
Van den bergh Indirect +  Direct + 
 
 Isolated rise of unconjugated  bilirubin– occurs in hemolytic disorders, 
genetic conditions  like Criggler- Najjar syndrome & Gilbert’s 
syndrome. 
 Conjugated hyperbilirubinemia – occurs in liver or biliary tract 
diseases. 
 Both are elevated in most of the  liver diseases. 
 URINE  BILIRUBIN: 
 Unconjugated  bilirubin – binds to albumin in serum and  is not 
filtered by the kidneys  
 Any bilirubin in urine is conjugated bilirubin fraction, the presence of 
bilirubinuria is seen in  liver diseases. 
 Urobilinogen is absent in urine  in  obstructive jaundice. 
 
 
 
 
 
20 
 
JAUNDICE 
DEFINITION: Yellowish discoloration  of the skin and sclera due to  
accumulation of the bilirubin  pigment  in the blood and tissues. For  
jaundice becomes clinically apparent the bilirubin level has to be more than 
35-40micomol/litre. 
Classification 
Prehepatic (haemotytic) jaundice 
-unconjugated hyperbilirubinemias 
Excess production of unconjugated bilirubin (from red blood cells) 
causes exhaustion of the ability of the liver to conjugate the extra load of 
bilirubin, e.g. congenital haemolytic anaemias like hereditary 
spherocytosis,thalassaemia , sickle cell disease and  hypersplenism . 
Hepatic (hepatocellurlar) jaundice 
Hepatic unconjugated hyperbiiirubinaemia 
Failure of transport of  the unconjugated bilirubin into the cell, 
e.g. Gilbert's syndrome 
Failure of activity of the enzyme bilirubin-glucuronide glucuronyl 
transferase, e.g. Crigler-Najjar syndrome 
Hepatic conjugated hyperbilirubinaemia 
Injury to the liver cells causes failure of excretion of 
bilirubin into the biliary system.  
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The common causes are: 
(a) Infections: viral hepatitis. 
(b) Poisons: carbon tetrachloride and aflatoxin 
(c) Drugs: paracetamol,anaesthatic agent- halothane 
Posthepatic (obstructive) jaundice 
       -Conjugated hyperbilirubinaemia 
Diseases which cause obstruction to the outflow of conjugated bilirubin from 
the hepatocyte or causing obstruction to the delivery of  the same conjugated 
bilirubin into the duodenum are known to cause surgical jaundice. 
           e.g. choledocholithiasis, periampullary carcinomas, portal 
lymphadenopathy, carcinoma head of pancreas. 
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LIVER FUNCTION TESTS:
[21] 
 Non-invasive method of screening for the presence of liver 
dysfunction 
 Pattern of lab test abnormality causes recognition of the general type 
of disorder 
 To assess the severity and to  allow prediction of outcome 
 To follow the course of  disease, evaluate response to treatment given  
and adjust treatment when necessary 
LIMITATIONS: 
 Lack of sensitivity (may be normal in liver cell failure,cirrhosis) 
 Lack of specificity (aminotransferase levels may be elevated in other 
disorders like musculoskeletal or cardiac disease) 
 Results suggest general category of liver disease, not a specific 
diagnosis 
 Need to use LFT as a battery of tests and repeat them over time 
CATEGORIES OF TESTS: 
 Tests for the capacity of the liver to transport organic anions and to 
metabolize drugs 
Eg. Serum  bilirubin, serum bile acids. 
Measures ability of the liver to clear endogenous or exogenous substances 
from the body circulation 
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 Tests to detect hepatocytes injury  
All the enzyme tests 
Most commonly done and most useful are aminotransferases and alkaline 
phosphatase  
 Tests for  the biosynthetic capacity of the liver 
Eg. Serum  albumin, prothrombin time 
 Tests to find out  fibrosis in the liver 
Eg. Type 4 collagen, Fibrotest  
 Tests for chronic inflammation or altered immunoregulation  of the 
body: 
Eg.Immunoglobulins and specific antibodies 
SERUM BILIRUBIN: 
Normal value of total serum bilirubin is <1.0mg% 
Direct and Indirect fractions estimated  by Van Den Berg reaction. 
 Bilirubin reacts with diazo reagent to produce coloured  azo pigment . 
At pH 5 –pigment  becomes  purple . 
SERUM ENZYMES:To detect damage to liver: 
 Aminotransferases (AST,ALT)  
 Helpful in detecting hepatocellular diseases  such as hepatitis. 
ASPARTATE AMINOTRANSFERASE:(SGOT) 
Normal level- 12 to 38U/L 
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    2 Iso enzymes are present  cytoplasmic, mitochondrial 
 Mild degree of tissue injury – cytoplasmic form is detected in serum  
 Severe injury – mitochondrial type is detected in serum  
 Significant elevation – occurs in myocardial infarction 
 Moderate elevation occurs in – liver diseases. 
 AST –is found in  liver , skeletal muscle, kidneys, brain, cardiac 
muscles, lungs, leucocytes, pancreas, RBC. 
ALANINE AMINOTRANSFERASE:(SGPT) 
 Normal level: 7 – 41 U/L 
 ALT is found mainly in liver. 
 Upto 300U/L is  nonspecific , any type of liver disorder. 
 >1000U/L  occurs in  extensive hepatocellular damage ( viral 
hepatitis, ischemic liver injury , toxin /drug induced liver injury ) 
 Acute hepatocellular diseases – ALT >AST 
 Aminotransferases are usually  not  greatly elevated in obstructive 
jaundice. 
SERUM ENZYMES:That show the presence of cholestasis: 
 Alkaline Phosphatase (ALP) 
 5’Nucleotidase 
 Gamma glutamyl transpeptidase(GGT)  
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ALKALINE PHOSPHATASE: 
 Normal level:40 – 125 U/L 
Iso enzymes of ALP 
 Alpha -1 ALP –found in epithelial cells of biliary canaliculi , 
increased in obstructive jaundice. 
 Alpha-2 heat labile ALP – found in hepatic cells ;its increased in 
hepatitis 
 Alpha -2 heat stable ALP – placental origin,elevated in normal 
pregnancy 
 Pre Beta ALP – bone origin , increased in bone diseases  
 Gamma ALP – found in intestinal cells, increased in Ulcerative colitis  
 Leucocyte ALP – Increased in lymphoma, decreased in chronic 
myeloid leukemia. 
 Elevation of liver derived ALP – not totally specific for cholestasis .  
 >4 times rise is seen in cholestatic liver diseases, bone diseases with 
rapid bone turnover , infiltrative liver diseases. 
 Isolated elevation of ALP – is seen in Hodgkins lymphoma, diabetes, 
CHF hyperthyroidism, inflammatory bowel diseases,amyloidosis. 
 Its’not helpful in differentiating between intrahepatic and extrahepatic 
cholestasis.  
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5’NUCLEOTIDASE: 
 Normal level :2 – 10 U/L 
 Moderately  elevated in hepatitis 
 Highly elevated in biliary obstruction. 
GAMMA GLUTAMYL TRANSPEPTIDASE:(GGT) 
 Used in body for synthesis  of glutathione 
 11 isoenzymes are present 
 Seen in liver, kidney, intestinal cells, prostate, pancreas. 
 Normal level: 9 – 58 U/L 
 Raised even when other LFT are normal in alcoholics. 
 Moderate rise –is seen in infective hepatitis, prostatic Carcinoma 
 High rise is seen in alcoholism, neoplasms of liver ,obstructive 
jaundice. 
SERUM ALBUMIN: 
 Produced by hepatocytes  
 Normal value is : 3.5 – 5 g/dl  
 Because of slow turnover- Serum albumin is not a good indicator of 
acute or mild hepatic dysfunction. 
 < 3 g/dl in hepatitis suggests  possibility of Chronic liver diseases. 
 Hypoalbuminemia – is seen in chronic.liver.diseases ( cirrhosis ), 
Ascites, protein malnutrition. 
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SERUM GLOBULINS: 
 Increased stimulation peripheral ReticuloEndothelial System due to  
shunting of antigens past liver and  impaired clearance by kupffer cells 
 Normal value : 2 – 3.5 g/dl 
 Increased gamma globulins and reversal in albumin globulin ratio – 
suggests liver cell pathology. 
PROTHROMBIN TIME:(PT) 
 Normal value is: 11.5 – 12.5 sec 
 Prolongation of PT by 2 sec or more is abnormal 
 PT is influenced by factors II,V, VII, X 
 Half life 6 hrs – for factor VII , 5 days –  for fibrinogen 
 PT prolonged –in  hepatitis, cirrhosis, vit K deficiency (obstructive 
jaundice, fat malabsorption)  
 in vit K deficiency, vit K 10 mg Subcutaneously  decreases prolonged  
PT >30% within 24 hours 
INR (international normalised ratio)  
 More frequently used tested  
 Standardising the  reports of PT 
 Avoids interlab variability 
 INR = [Patient Prothrombin Time/mean control ProthrombinTime] ISI 
  ISI - international sensitivity index 
28 
 
NORMAL VALUES: 
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QUANTITATIVE TESTS FOR LIVER FUNCTION: 
• More sensitive tests 
• Limitations of biochemical tests 
• Expensive and there is requirement of  research centers 
• Trials are  needed before wider acceptance 
Indocyanine  green clearance test. 
14
C - aminopyrine breath test 
Antipyrine  clearance test. 
Galactose elimination capacity 
13
C - caffeine breath test using  radiolabelled carbon 
13
C. 
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OBSTRUCTIVE JAUNDICE 
Obstructive Jaundice is a  most common surgical problem that occurs 
when there is an obstruction to the outflow of conjugated bilirubin from the 
hepatocytes to the intestine. 
Jaundice due to biliary obstruction is caused by a heterogeneous group 
of diseases that include both benign and malignant conditions .Obstructive 
jaundice is not a definitive diagnosis. Pathological changes like  secondary 
biliary cirrhosis can occur if obstruction is unrelieved and the disease has a 
high mortality rate.So early investigation to find out the correct etiology is of 
great importance. 
CLINICAL FEATURES:
[18] 
 Patients present with complaints of yellowish discoloration of skin and 
sclera, clay colored stools, high colored urine and itching. Some have 
history of abdominal pain, generalized weakness & fatiguability, 
weight loss ,reduced appetite 
 Patients with periampullary carcinoma give history of waxing and 
waning of jaundice and silvery stools. 
Important points in history: 
Duration of Jaundice; Progress & previous attacks of jaundice 
Abdominal pain: Biliary/pancreatic/Dull 
Pruritis, Colour of urine and stool 
Manifestations of fat soluble Vitamin deficiency 
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Weight loss 
Drug ingestion 
History of injections or blood transfusions 
Prodrome of anorexia, nausea, vomiting 
Pruritis  
Clay coloured stools 
Fever 
On Examination: Vital signs: Pulse, Blood pressure; Pallor due to GI 
bleeding, Hemolysis ,Icterus ,Pedal oedema due to hypoproteinemia or 
cirrhosis ,Shiny nail & scratch marks caused by pruritis, Xanthoma, 
Ecchymosis, Bitot spots  caused by Vitamin deficiency. 
 Look for icterus-yellowish discoloration in sclera, undersurface of the 
tongue, palms, nails, skin, hard-palate due to high affinity of bilirubin  
for collagenous tissue . 
 In obstructive jaundice icterus is greenish yellow in color.  
Abdomen examination: 
 Abdominal distension, distended veins. 
 Hepatomegaly  
 Splenomegaly  
 Gall bladder or any mass,  
 Free fluid 
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COURVOISIER’S LAW: 
If the CBD is obstructed due to  calculus , the GB is usually not 
distended owing to previous inflammatory fibrosis and so not palpable.  
In obstruction of the CBD due to growth in periampullary region or 
head of pancreas , the GB becomes distended in order to reduce the pressure 
in the biliary system and gall bladder is palpable. 
Exceptions to Courvoisier’s law: 
- double impaction of stone in cystic duct and CBD 
- mucocele and empyema of gall bladder 
- oriental cholangiohepatitis 
COMPLICATIONS OF OBSTRUCTIVE JAUNDICE:[15] 
Complications due to obstructive jaundice are 
 cholangitis, and other forms of  sepsis.  
 biliary cirrhosis,  
 pancreatitis,  
 coagulation failure,  
 renal shut down and  
 liver failure.  
Complications can also occur due to the procedures employed in the 
investigation and management of individual diseases causing surgical 
jaundice. Choledocholithiasis can lead do cholangitis of suppurative type 
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causing Charcot’s triad and Raynaud’s pentad. ERCP is an invasive 
investigation associated with the development of cholangitis. Treatment of 
cholangitis are correction of coagulopathy, correction of fluid and electrolyte 
abnormality, drainage of bile and antibiotics . 
CAUSES FOR OBSTRUCTIVE JAUNDICE: 
IN THE LUMEN: 
Stones  in common bile duct 
Parasitic infestations-Schistosomiasis, ascariasis 
Hemobilia 
Ascending cholangitis 
IN THE WALL: 
Stricture in the common bile duct 
Cholangiocarcinoma 
Periampullary carcinoma 
Sclerosing cholangitis 
Choledochal cyst 
Biliary atresia 
Klatskin tumour 
OUTSIDE THE WALL: 
Carcinoma head of pancreas;  
Porta hepatis lymph nodes. 
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Benjamin’s classification of  biliary obstruction: 
Type 1:complete obstruction 
Pancreatic and cholangiocarcinoma, iatrgenic CBD ligation 
Type 2:Intermittent obstruction 
CBD stones, periampullary tumour, choledochal cyst, hemobilia 
Type 3:chronic complete obstruction 
CBD stricture, traumatic, cystic fibrosis 
Type 4:segmental obstruction 
Sclerosing cholangitis, cholangiocarcinoma 
Intrahepatic biliary stones. 
CHOLEDOCHOLITHIASIS:
[17] 
It presents with charcot’s triad- intermittent pain, fever and jaundice. 
Stones are mostly from gall bladder. It can also be due to primary 
choledocholithiasis which are pigment stones. 
Primary-brown pigment stones 
Secondary-75% cholesterol stones, 25%  black pigment stones 
CBD STRICTURE: 
It can be benign or malignant. Causes for benign stricture are trauma, 
iatrogenic injury during cholecystectomy, liver surgery, gastrectomy or 
inflammatory .Malignant ones present with an underlying growth. 
Depending on the site of stricture 5 classes are described by BISMUTH. 
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CHOLEDOCHAL CYST:
[18] 
According to TODANI  classification there are 5 types of choledochal 
cysts: 
Type I a & b : diffuse cystic. Most common accounting to 75% 
Type II  : diverticulum of the common bile duct-supraduodenal  
  diverticulum 
Type III : diverticulum within the pancreas-choledochocele. 
 Type IV : extension into the liver-multiple intra and extra-hepatic cysts.  
Type V : cystic dilatation only in the intrahepatic ducts-Caroli’s disease 
                             They present with triad of right upper quadrant pain, 
jaundice, and an abdominal mass. Incidence of cholangiocarcinoma is higher 
than in general population. 
PERIAMPULLARY CARCINOMA: 
Peri-ampullary cancers can be defined  as tumors arising within 1 cm 
of the ampulla of Vater and include ampullary, distal bile duct, pancreatic, 
and duodenal cancers. However, without careful histological analysis, it is 
difficult to differentiate the tumor type correctly. 
They present with waxing and waning of jaundice and silvery stools. 
CARCINOMA HEAD OF PANCREAS: 
Pancreatic ductal adenocarcinoma is one the most lethal GI 
malignancy with an overall 5-year survival rate of less than 4%. Factors 
influencing this grave prognosis are  
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1) In the early stages of the disease  clinical symptoms  are usually absent or 
non specific resulting in late diagnosis, and only 15–20% of tumors are  
resectable at the time of presentation.  
2) Tumour is very aggressive  with retroperitoneal and perineural infiltration, 
high local relapse rates, angioinvasion,  formation of metastases, and 
3) Tumour does not respond to most of the available treatment regimens, 
making management of the patient a complex and difficult task. 
CHOLANGIOCARCINOMA: 
Cholangiocarcinomas are epithelial cancers of the cholangiocytes and 
they may occur at any level of the biliary tree.  
           They are broadly classified into intra-hepatic tumours, extra-hepatic 
hilar tumours and extra-hepatic distal bile duct tumours. Hilar 
cholangiocarcinoma accounts for two thirds of all cases of extra-hepatic 
cholangiocarcinoma. 
Majority  of these tumours arise in the absence of risk factors.Some of 
the risk factors are age, primary sclerosing cholangitis, bile duct adenoma, 
biliary papillomatosis, Caroli’s disease, choledochal cyst, chronic 
choledocholithiasis, smoking, chronic typhoid carrier state and parasitic 
biliary infestation.  
 
 
 
37 
 
KLATSKIN TUMOUR: 
Tumour occurring at the confluence of both hepatic ducts-where left 
and right hepatic ducts join to form common hepatic duct is called Klatskin 
tumour. 
CARCINOMA GALL BLADDER: 
3% of gall stones with cholecystitis will present with carcinoma gall 
bladder. It can spread to liver, duodenum locally, lymphatic spread through 
lymph node of lund and peripancreatic nodes, blood spread to lungs and 
bones. Nevin’s staging is used to stage the tumour. 
INVESTIGATIONS FOR OBSTRUCTIVE JAUNDICE: 
 Bilirubin, Serum enzymes  (SGOT, SGPT) 
 Alkaline phosphatase, GGT, 5'-nucleotidase 
 Proteins: Albumin, Globulins,  
 Bleeding time,Clotting time  
 Prothrombin time,aPTT. 
 Urine tests 
 Ultrasound, CT scan 
 ERCP and Percutaneous Transhepatic Cholangiography  
 Magnetic resonance cholangiopancreaticography  
 Tumour markers 
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ERCP and MRCP were done only in affordable cases in my study.PTC is not 
available in our institution and so not done. 
Biochemistry/Hematology: 
          Elevated total serum bilirubin level and high levels of the conjugated 
fraction of bilirubin is usually seen. In general, patients with benign disease 
have less hyperbilirubinemia than those with malignant obstruction.  
         The transaminases (AST & ALT) may rise abruptly  many fold above 
normal. Alkaline phosphatase and gamma glutamyltransferase are important 
markers for cholestasis. When the obstruction to outflow of bile rises 
progressively, the levels of these two markers rise several times above  the 
normal level. 
URINE TESTS: 
Fouchet’s test for bile pigments 
Hay’s test for bile salts 
Ehrlich’s test for urobilinogen 
Radiological Imaging: 
The indications for radiological imaging in obstructive jaundice cases 
are: 
(1) to confirm the presence of biliary system obstruction in order to 
differentiate surgical and medical jaundice ,  
(2) to find out the level of the obstruction-intra or extra hepatic 
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(3) to identify the specific cause and pathology causing obstruction to biliary 
flow,and  
(4) to provide additional information related to the underlying diagnosis such 
as staging information in cases of carcinomas. 
The radiological investigations available for the diagnosis of obstructive 
jaundice can be divided into  
noninvasive -ultrasonography, CT scan & MRCP and  
invasive- ERCP and PTC. 
A plain abdominal x ray : 
Not much useful. 
It can identify calcified gallstones, porcelain gallbladder, 
air in the biliary tract or air in the gallbladder wall . 
Abdominal ultrasonography : 
Ultrasound is the most widely used imaging method, which is due to 
its non-invasive and non-radiating character, the absence of documented side 
effects, its non-painful and non-bleeding nature, as well as to its relatively 
high accuracy allowing the detection of tumor formations up to 1 mm in size. 
Conventional ultrasound uses, planes or sections through the anatomic areas 
of interest. The limitations of this method are known, the most important one 
being represented by the planar or two dimensional character (2D). These 
limitations result in an impossibility to get information on the coronal plane 
for unpaired organs situated on the median line of the body, information 
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which is sometimes required for a better tumor staging or just for a better 
understanding of normal topography. The two-dimensional character of the 
investigation also prevents a better representation of the surfaces of normal 
or pathological structures, information which is frequently “reconstructed” in 
the examiner’s imagination, that confers a marked subjectivity to the 
ultrasonographic  method . 
Three-dimensional ultrasound can be performed concomitantly with 
2D ultrasound or it can be resumed and finalized in a second stage, by the 
use of an external work station, after the patient has left the department. This 
is represented by a network of computer connected to the ultrasound 
machine, which functions as a second examining machine. 
Tumors up to 10 mm in size can be accurately detected and 
information on their position in relation to the reference vessels: hepatic 
veins, inferior vena cava, and portal veins  can be obtained. Using the 
volume function, accurate information on the real size of a tumor mass can 
be obtained and oncological safety elements can be added, including the 
application of a parenchymal layer with predetermined thickness that might 
allow the surgeon to assess the tissue volume to be removed. This 
information is particularly important, as it may be a decisive element in 
establishing whether surgery is indicated or for choosing another therapeutic 
solution such as radiofrequency ablation or percutaneous alcoholization . 
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It is extremely useful, for surgeons in particular, to understand the 
spatial position of a structure at the level of the biliary tree in relation to 
hepatic segmentation. The operative strategy and  final results often depend 
on this component. Three-dimensional ultrasound allows the spatial 
representation of anatomic structures and facilitates, by means of special 
software, the spatial rotation of the volume and a cut-out within it. 
The bile ducts and the hepatic vessels can be relatively easily 
differentiated by the rotation of the volume around the longitudinal axis, that 
allows their dissociation. In addition, the rotation of the volume around a 
transverse axis allows the exploration of the hepatic hilum, the examination 
being highly similar to an  intraoperative macroscopic examination. 
The diagnostic performance of 3D ultrasound increases when the bile 
ducts are dilated. The explanation is that cystic aspects are easier to evidence 
using the transparent and inverse mode software. The spatial disposition of 
the bile ducts is more clear and the distance between the hepatic ducts in the 
case of a Klatskin tumor is more easy to assess by this technique. The best 
known application of this method is the characterization of biliary cysts 
whose spatial distribution is extremely easy to evidence  
The introduction of this technique into clinical practice is very  recent, 
therefore more extensive studies over longer periods and on larger patient 
groups are expected in order to assess its usefulness in routine examinations. 
42 
 
Endoscopic ultrasonography :(EUS) 
EUS has variety of applications, with regard to the biliary system, 
EUS is useful for the diagnosis and staging of ampullary tumors, detection of 
microcalculi, choledocholithiasis and evaluation of benign and malignant 
biliary  strictures. It can help us to identify the involvement of portal venous 
system. Endoscopic ultrasound is also useful to aspirate cysts and take 
guided biopsy from solid lesions, EUS guided FNAC, celiac axis neurolysis, 
EUS guided immunotherapy but is operator-dependent and not readily 
available in most centers.  
Computed tomography (CT): 
CT  of the abdomen provides excellent visualization of the liver, 
gallbladder, pancreas, kidneys, and retroperitoneum. CT  is helpful to 
differentiate between intra- and extra-hepatic obstruction with very high 
accuracy. CT helps to assess the operability of tumours in malignant 
obstruction. 
Contrast-enhanced multi-slice CT : 
It is very useful for assessment of biliary malignancies. 
Contrast agents given orally or intravenously are used and imaging 
done in unenhanced, arterial and venous phases. CT  angiogram or venogram 
to assess vascularity and portal venous system in malignancy. 
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ERCP (Endoscopic Retrograde Cholangiopancreatography ) 
Endoscopic Retrograde Cholangiopancreatography (ERCP) is gold 
standard in evaluation of obstructive jaundice. ERCP detects obstruction 
below the confluence of right and left hepatic ducts 
ERCP can be used both for diagnostic and therapeutic purposes. 
Diagnostic-It can pick up CBD stones, strictures of CBD, 
periampullary carcinoma, any obstruction of the CBD as well as helps in 
taking the brush  cytology. 
Therapeutic-Its used in stone removal using dormia basket, lithotripsy 
after sphincterotomy; balloon dilatation for stricture; placing stents in 
inoperable tumours and stricture. 
PTC (Percutaneous transhepatic cholangiography): 
It is used  to detect obstruction below the level  of confluence of right 
and left hepatic ducts. 
PTC combined with biliary drainage is done as a diagnostic and 
palliative/ presurgical procedure to improve patient condition/ 
outcome.Polythene catheter can be kept in situ to have biliary drainage.It is 
used to decompress,assess proximal dilated obstructed biliary system when 
ERCP fails and stenting across the obstruction can be done under image 
guidance. 
However ERCP and PTC are invasive investigations .There are some 
complications with their use. These include infection and cholangitis, 
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pancreatitis, biliary leakage,and bleeding.Also these investigations require 
specific expertise and equipment which  are  of   limited availability. 
Magnetic resonance cholangiopancreatography (MRCP) : 
Magnetic Resonance Cholangiopancreatography is a relatively new 
MR imaging technique which has revolutionized the imaging of biliary and 
pancreatic ducts and has emerged as an accurate, non-invasive means of 
visualization of the biliary tree and pancreatic duct without injection of 
contrast material. MR Cholangiopancreatography has undergone a wide 
variety of changes.  
Magnetic Resonance Cholangiopancreatography with its inherent high 
contrast resolution, multiplanar capability ,rapidity and virtually artifact free 
display of anatomy and pathology, has proved to be the imaging of choice in 
these patients.  
 MRCP shows the entire biliary tract and pancreatic duct without any 
intervention and use of oral or IV contrast. The quality of images obtained  is 
comparable with those of direct cholangiography procedures like ERCP, 
which is considered as standard of reference in biliary ductal pathologies.  
The diagnostic accuracy of MRCP suggests that, it has the capacity to 
replace the more invasive procedures like diagnostic ERCP, which should be 
used only in cases where intervention is being contemplated. 
It has proved effective in demonstrating bile duct dilatation, stricture 
and choledocholithiasis. In patients with malignant obstruction or stenosis of 
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biliary-enteric anastomosis, this type of  noninvasive imaging technique 
demonstrates the site and extent of the stenosis, the presence and size of 
biliary stones, the degree of proximal dilatation and other associated 
findings. 
TUMOR MARKERS: 
Tumour markers like CA 19-9, CEA and CA-125 are useful in 
malignant obstruction.CA 19/9 is useful for pancreatic carcinoma with 70% 
sensitivity and 90%specificity.It is more than 70units/litre.But it may also 
rise in other causes of biliary obstruction and cystadenoma. 
TREATMENT: 
Surgical treatment is planned according to the etiology. Extrahepatic 
biliary obstruction requires mechanical decompression. Other goals include 
treatment of the underlying cause, symptoms, and complications (e.g., 
vitamin malabsorption). Decompression of extrahepatic biliary obstruction 
can be achieved by any of these three methods: surgical bypass, resection of 
obstructing lesions, percutaneous or endoscopic insertion of stents.  
PRE-OPERATIVE PREPARATION OF THE PATIENT: 
Proper diagnosis and assessment 
Vitamin K injection 10 mg intramuscularly for 5 days 
Adequate hydration with 5% or 10% dextrose 
Fresh frozen plasma-requires 6 bottles or more 
Blood transfusion in case of anaemia 
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Oral neomycin, lactulose 
Mannitol 100 to 200 ml intravenously twice daily to prevent 
hepatorenal syndrome 
Repeated monitoring by doing prothrombin time,electrolytes 
Antibiotics like third generation cephalosporins 
Calcium supplementation in the form of calcium chloride 
Preoperative biliary decompression is indicated if bilirubin level is 
more than 12 mg%, sepsis, severe malnutrition, hepatorenal syndrome, 
cardiopulmonary disease. 
Correction of coagulopathy, prevention of renal failure, infection, 
hepatic encephalopathy, electrolyte imbalance 
Correction of hypoglycemia and dilutional hyponatremia due to water 
retention and avoiding isotonic saline infusion. 
MANAGEMENT OF PRURITIS: 
            Pruritis may be due to retention of bile salts which activates release 
of histamine in skin, central mechanism or by release of endogenous opioids. 
It is often difficult to treat. Once cause is treated and obstruction is relieved 
pruritis regresses. Drugs and therapies used are-Cholestyramine-its an ion 
exchange resin which bind bile salts in intestine inhibiting their absorption. 
Other drugs used are rifampicin, gabapentin. ondensetran, sertraline, 
ursodeoxycholic acid, antioxidants, phototherapy, plasmapheresis. 
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CHOLEDOCHOLITHIASIS: 
For proximal stones-open or laparascopic cholecystectomy 
cholecystectomy, choledocholithotomy and removal of stones followed by 
choledochoduodenostomy. 
For distal stones-Laparascopic cholecystectomy; ERCP and 
papillotomy ;stone extraction through dormia basket or balloon catheter ; or 
fragmenting the stone and extraction or removal through baby endoscope. 
CBD stent can be placed in situ. 
CBD STRICTURE: 
Treatment of stricture is operative resection or bypass if extrahepatic ; 
endoscopic stenting of dominant stricture  if available. 
For lower 1/3 stricture-ERCP and sphincterotomy ;or transduodenal 
sphincterotomy ;or sphincteroplasty 
For middle 1/3-ERCP and  balloon dilatation ; or stenting; or by-pass 
For upper 1/3-porto enterostomy ; HEPP-Couinaud by-pass with 
segment III of liver. 
CHOLEDOCHAL CYST: 
Type I-excision and roux-en-y hepatico jejunostomy 
Type II-excision and suturing of CBD wall 
Type III-endoscopic sphincterotomy 
Type IV-Lily’s procedure leaving back the serosa  of posterior wall which is 
adherent to the portal vein. 
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Type V(Caroli’s disease)-liver transplantation.  
MALIGNANCIES: 
For lesions that are resectable or amenable to surgical palliation, the 
choice of treatment will depend on the level of obstruction and the precise 
etiology. For this purpose, the lesions can be classified into three: 
a) Upper third obstruction  
Surgical palliation is best achieved with a left hepaticojejunostomy .The long 
extrahepatic course of the left hepatic duct makes it more accessible. For 
respectable lesions, the tumor is resected with a possible hepatectomy or 
segmentectomy and reconstruction achieved by hepaticojejunostomy.  
b) Middle third obstruction  
Surgical palliation is better and hepaticojejunostomy after the bifurcation is 
done. If tumor is resectable, reconstruction is achieved with 
hepaticojejunostomy.  
c) Lower third obstruction  :  
Surgical palliation done using a Roux en Y choledochojejunostomy. 
Cholecystojejunostomy carries a high risk of complications and subsequent 
jaundice. If tumor is resectable, a pancreatiduodenectomy  by Whipple’s 
procedure  or local ampullary resection should be done.  
Palliation of inoperable pancreatico-biliary malignancies : 
Malignant obstructive jaundice cases can receive  adequate palliation 
with ERCP by biliary drainage and endoscopic stenting. Percutaneous 
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transhepatic approach is also used as an alternative to ERCP in biliary 
decompression,but it is reserved for those patients with duodenal obstruction 
or failed ERCP. A diagnostic ERCP is necessary before to stent insertion to 
evaluate the extrahepatic duct system  
Types of stents  
a) Plastic stents- These are mostly made of polyethylene. The plastic stents 
can maintain patency for about 2to 4 months .Important complications 
associated with plastic stents are stent occlusion, fracture, migration and  
sepsis. Reccurrence of jaundice or cholangitis can occur due to stent 
occlusion requiring exchange  of stent in 30-60% of cases.  
b) Metal stents- are made of stainless steel alloy monofilament or nickel 
titanium alloy and are self expandable. Mechanisms by which self 
expandable metallic stents can be occluded are biliary sludge, tumor 
ingrowth or over growth, and epithelial hyperplasia. These metal stents can 
also be covered with silicon membrane to prevent tumor in growth and now 
there are  biodegradable stents in use.  
PERIAMPULLARY CARCINOMA: 
The mainstay of treatment for peri-ampullary cancers is surgical 
resection. Preoperative staging and assessment of resectability is important. 
The  procedure of choice is a pancreaticoduodenectomy if the tumor is can 
be resected . 
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Whipple’s procedure or cWhipple is the classical approach  for 
pancreaticoduodenectomy  described by Kausch and Whipple and the most 
popular technique. The more conservative approach  or pylorus preserving 
Whipple resection or ppWhipple described by Watson in 1943 and later 
popularized by Traverso and Longmire are other techniques that are 
gradually gaining more importance.  
The advantages of Pylorus-preserving pancreaticoduodenectomy are  
easier and less time-consuming operation with less blood loss, a short 
hospital stay, and better weight gain during follow-up care. Also, between 
pylorus-preserving pancreaticoduodenectomy and the standard Whipple 
procedure there are no differences in the recurrence rate and patient survival. 
For inoperable cases, palliative treatment is given depending on the 
comorbidities, availability of resources and expertise for endoscopic 
treatment. Biliary bypass proceduresfor palliation  can be done operatively, 
laparoscopically, endoscopic stenting or by percutaneous transhepatic 
approaches.  
In patients with gastric outlet obstruction  Gastric bypass procedures 
are also indicated . It has been found by various trials that a prophylactic 
gastrojejunostomy significantly decreases the incidence of late gastric outlet 
obstruction and does not increase the incidence of postoperative 
complications or increase the length of  hospital stay.  
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CARCINOMA HEAD OF PANCREAS: 
Surgery is the only curative modality of treatment, but unfortunately 
less than 20% of the tumours are resectable. There is now an acceptable 
operative mortality rate of less than or equal to 5% for resected patients 
when performed at experienced centres with high volume of patients . 
The treatment options for pancreatic cancers are closely similar to 
peri-ampullary cancers. Tumour shows some response to agents like 
Gemcitabine, 5FU .Pain Palliation- patients who present with severe pain 
should receive opioids. Morphine is usually  the drug of choice. Usually, the 
oral route is preferred in routine practice. Parenteral routes of administration 
are considered for patients who have impaired swallowing or gastrointestinal 
obstruction. Percutaneous celiac plexus blockade should  be considered, 
especially for patients who have  poor tolerance to opiate analgesics.  
CHOLANGIOCARCINOMA:   
The only curative modality of treatment for cholangiocarcinoma is 
also surgery. Extent of spread, available surgical expertise and associated co-
morbidities are some of the factors that determine the therapeutic approach 
to the patient.                                   
Preoperative staging with an aggressive onco-surgical approach 
involving en-bloc hilar or hepatic resections are being advocated recently. 
Currently procedures like  cholecystectomy, lobar or extended lobar hepatic 
and bile duct resection, regional lymphadenectomy, and Roux-en-Y 
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hepaticojejunostomy are the treatments of choice for hilar 
cholangiocarcinoma. Photofrin based photodynamic therapy  is being tried 
very recently with encouraging results.  
Systemic therapy/Palliative therapy : 
Most of them present with advanced stage of disease and co-
morbidities and so   surgery is an impossible treatment option for them. 
Biliary endoprosthesis (stent) placement is a useful option for palliation of 
jaundice. ERCP for distal lesions and transhepatic route for proximal lesions 
are preferred.Other Palliative options available are photodynamic therapy, 
radiation and chemotherapy. Gemcitabine or 5-Fluorouracil are the two 
common agents which used either as a single agent or in combination with 
other drugs.  
GALL BLADDER CARCINOMA: 
          In operable cases extended cholecystectomy with removal of segments 
IV and V of liver  and perihepatic nodal clearance or  hemihepatectomy with 
cholecystectomy with node clearance.In inoperable cases systemic or intra-
arterial chemotherapy and adjuvant radiotherapy. 
POST-OPERATIVE CARE: 
Monitoring with prothrombin time, bilirubin level, albumin, creatinine, 
electrolyte estimation    
FFP and blood transfusion 
Antibiotics 
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Observation for septicemia, hemorrhage, pneumonia, bile leak, pleural 
effusion 
TPN.CVP line, nasogastric tube, urinary catheter. 
RECOMMENDATIONS :[11] 
1. Based on  factors concerned with the patient  and availability of 
equipments and personnel, treatment should be individualized for all 
patients 2. Dedicated centres should be set up in order to  maximize 
treatment for pancreatic cancers and other cancers. 
2. Pylorus preserving pancreaticoduodenectomy which are easier and 
less time consuming are now-a-days instead of the Classical 
Whipple’s resection. 
3. Extensive palliative resections and other procedures are associated 
with a high degree of morbidity and mortality in advanced 
hepatobiliary malignancies and should not be encouraged.  
4. Training in all types of endoscopic procedures is very much needed 
for all surgeons.  
5. For biliary decompression by trans-hepatic drainage  ERCP is the 
preferred modality except for obstructions near the hepatic bifurcation. 
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MATERIALS AND METHODS 
 
This study was conducted by randomly selecting 50 cases admitted 
and treated for obstructive jaundice in our wards under various units in the 
Department of General Surgery, Tirunelveli medical college during the year 
2012 to 2013. 
INCLUSION CRITERIA: 
Patients of any age or sex admitted with complaints of jaundice and 
clinically and biochemically diagnosed to have obstructive jaundice. 
Patients diagnosed as having obstructive jaundice are evaluated based 
on different criterias. 
Clinically-Mucus membranes of mouth, palm and sole and sclera are 
examined in natural light for jaundice. 
Cholestatic syndrome-signs and symptoms related to conjugated 
hyperbilirubinemia and chronic malabsorption of fat soluble 
vitamins(Vitamins A,D,E and K)-Jaundice,dark urine,pale 
stools,pruritis,bruising,steatorrhoea,night blindness,osteomalacia,neuro 
muscular weakness. 
Biochemically 
1. Van den berg/Diazo reaction-conjugated hyperbilirubinemia. 
2. Serum bilirubin levels-elevated direct bilirubin 
3. Enzyme levels-elevated alkaline phosphatase. 
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PATIENTS ARE EVALUATED BY: 
 Age  
 Sex  
 Chief complaints at the time of presentation 
 Cause for surgical jaundice 
 USG finding 
 CT  Abdomen correlation 
 Morbidity and Mortality due to the disease 
 Treatment given 
 Morbidities following treatment 
 Malignancies causing obstructive jaundice 
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Figure 8:CT ABDOMEN  CONTRAST  SHOWING INTRA-HEPATIC 
BILIARY RADICLE DILATATION 
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Figure 9:MRI ABDOMEN –AXIAL VIEW- SHOWING CARCINOMA 
HEAD OF PANCREAS 
 
Figure 10:MRI ABDOMEN SAGITTAL VIEW-CARCINOMA HEAD OF 
PANCREAS. 
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OBSERVATIONS 
 
The study comprised of 50 patients with obstructive jaundice. 
Table 2 : AGE DISTRIBUTION 
Age                                   No of Cases Percentage 
<30yrs    2 4% 
30-40yrs  6 12% 
40-50yrs 12 24% 
50-60yrs                               19 38% 
60-70yrs 8 16% 
>70yrs 3 6% 
 
 
The most common age group affected with obsrructive jaundice in my study 
is 50-60yrs. 
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Table 3 : SEX DISTRIBUTION 
 
        Sex                  No of cases Percentage 
MALE 28 56% 
FEMALE  22 44% 
 
 
 
 
There is a male preponderance with about 56% of the affected patients 
being male. 
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Table 4 : CHIEF COMPLAINT 
 
                    Complaint                      No of cases Percentage 
JAUNDICE   27 54% 
ABDOMINAL PAIN  20 40% 
VOMITING 19 38% 
ABDOMINAL DISTENSION  3 6% 
ITCHING  2 4% 
LOSS OF APPETITE 1 2% 
 
 
 
The most common complaint was yellowish discoloration of skin and 
sclera accounting for 54%.Some patients had two chief complaints in 
combination like abdominal pain and vomiting in malignancies. 
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Table 5 : ETIOLOGY 
 
             Etiology                No of cases Percentage 
BENIGN 15 30% 
MALIGNANT                             35 70% 
 
 
 
 
Among 50 cases studied 15 cases had a benign etiology and 35 cases 
had a malignant etiology accounting for 70%. 
This shows the high morbidity and mortality of the disease. 
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Table 6 : BENIGN ETIOLOGY: 
 
                   Causes                                  No. of cases Percentage 
CHOLEDOCHOLITHIASIS 11 22% 
CBD STRICTURE 3 6% 
CHOLEDOCHAL CYST 1 2% 
 
 
 
 
Choledocholithiasis  accounts for about 22% of the overall etiology of 
obstructive jaundice and about 73.3% of the benign causes. 
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Table 7 : MALIGNANT CAUSES 
                           Causes                                    No. of cases Percentage 
PERIAMPULLARY CARCINOMA   12 24% 
CARCINOMA HEAD OF PANCREAS  7 14% 
LIVER SECONDARIES WITH PORTA 
 HEPATIS NODES  6 
12% 
CHOLANGIOCARCINOMA  5 10% 
D2 DUODENAL CARCINOMA 2 4% 
KLATSKIN TUMOUR                                                 2 4% 
GALL BLADDER CARCINOMA                               1 2% 
 
 
Periampullary carcinoma appears to be the most common cause 
accounting for 34% of malignancies . 
 
 
 
0%
5%
10%
15%
20%
25%
24% 
14% 
12% 
10% 
4% 4% 
2% 
64 
 
 
Table 8 : ULTRASONOGRAPHIC FEATURES 
                 Features                            No. of cases     Percentage 
CBD DILATATION     30                         64% 
GROWTH     14                        30% 
STONES       3                         6% 
 
 
 
 
All the cases showed dilatation of intrahepatic  biliary radicles. About  
64% of cases had CBD dilatation in USG. Both IHBR and CBD dilatation 
was present in 24 cases in ultrasonography. 
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Table 9 : CT ABDOMEN 
 
Features No. of cases Percentage 
BILIARY TRACT 
DILATATION 
          9 30% 
ASCITES         10 33% 
LYMPHADENOPATHY         11 37% 
 
 
 
CT Abdomen both plain and contrast was done for all cases. It 
identified the etiology of obstruction in all the 50 cases. Other features like 
ascites and lymphadenopathy were also noted. Thus CT has better accuracy 
in identification of cause than USG. 
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Table 10 : MORBIDITY AND MORTALITY CAUSED BY 
OBSTRUCTIVE JAUNDICE 
 No. of Cases Percentage 
CACHEXIA 25 29% 
ASCITES 31 36% 
LIVER SECONDARIES 13 15% 
ANOREXIA 8 9% 
GOO 5 6% 
CHOLANGITIS 2 2% 
DEATH 3 3% 
 
 
Mortality due to the disease is 3% of morbidities and 6% in overall 
population included in the study. Most of them who had malignant cachexia 
also had ascites . 
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Table 11 : TREATMENT GIVEN: 
 
Treatment No. of cases Percentage 
SURGERY 25 50% 
PALLIATIVE TREATMENT 16 32% 
REFERRAL 6 12% 
NON-COMPLIANCE 3 6% 
 
 
 
About 25 cases were treated surgically accounting for 50%.Other 32% 
were given palliative therapy in the form of chemotherapy and 2 cases 
received ascitic fluid tapping. 
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Table 12 :TYPE OF SURGERY 
Type of surgery No. of 
cases 
Percentage 
TRIPLE BYPASS 11 44% 
CHOLEDOCHOLITHOTOMY AND 
CHOLEDOCHODUODENOSTOMY 
11 44% 
OTHER BYPASS PROCEDURES 3 12% 
 
 
 
About 44% cases were treated with triple bypass for biliary drainage 
and gastrointestinal drainage.44%were treated with choledocholithotomy 
and choledochoduodenstomy for stone disease. 
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Table 13 : TREATMENT COMPLICATIONS 
Complications No. of cases Percentage 
UNEVENTFUL 24 48% 
INOPERABILITY 13 26% 
BILIARY GASTRITIS 8 16% 
WOUND INFECTION 4 8% 
DEATH 1 2% 
 
 
 
Most of the cases were inoperable accounting for about  35% and they 
were treated with palliative therapy. Operated cases presented with other 
complications. 
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DISCUSSION 
In my study I have included 50 cases admitted and treated for 
obstructive jaundice in our hospital for a period of one and a half year. 
The most common age group affected with obstructive jaundice 
appears to be 50 to 60 years of age accounting to about  38% and the mean 
age group affected is 52.5 years-youngest being 20 years and eldest being 85 
years. The next most common age group appears to be 40-50 years and 60-
70 years with 24% and 16% respectively. Thus it appears to be a disease of 
elderly age group. 
The most commonly affected sex is male. In my study among the 50 
cases 28 patients are male accounting to about 56%.Malignant disease 
appears to be most common in elderly males .About 22 cases among 28 are 
affected by malignant obstructive jaundice. The ratio of male :female 
appears to be1.3:1 in our set up. 
This correlates with the study of S Verma et al
[1]
 in which the male: 
female ratio was 1.3:1 (56%:44%) and the most commonly affected age 
group was 50-60years(mean age affected 50.4 years) CHIEF 
COMPLAINTS: The most common chief complaint appears to be yellowish 
discoloration of skin and sclera i.e jaundice  in about 54% of patients. 
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Even according to Javeria Iqbal et al study jaundice was the chief 
complaint in most of the patients. 
          The next most common complaint is abdominal pain accounting to 
about 40%.Some patients have two complaints in combination like 
abdominal pain and vomiting. Among  the 8 cases with abdominal pain and 
vomiting ,5 are due to malignant etiology indicating outlet obstruction and 3 
are due to benign etiology. 
              Abdominal pain is present in most of the cases with stone disease. 
This goes with Kurram Siddique et al 
[4]
study where abdominal pain was 
commonest in benign disease (accounting to 51.66%). 
               Abdominal distension is present in patients with ascites with 
advanced malignancy. Itching is present in 4% of cases and indicates 
deposition of bile salts and bile pigments in nerve endings. These patients 
were treated with cholestyramine which acts as a blie acid sequestrant. The 
other  complaint is loss of appetite which indicates mucosal edema of the 
GIT and growth causing outlet obstruction. 
ETIOLOGY: 
          Among the 50 cases studied 35 have malignant etiology accounting to 
about 70%.Only 30% have a benign etiology. This indicates the high 
morbidity and mortality of the disease. Most of the cases presented with 
advanced malignancy and most of the cases were elderly males. 
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              This correlates with accuracy to the study of Khurram Siddique et 
al
[4 ]
who have stated that malignancy was the most common cause(occurring 
56.6% of the patients in his study) 
               The most common benign etiology appears to be 
choledocholithiasis accounting for about 22% of the overall etiology and 
73.3%  of the benign etiology. Among the 11 cases with choledocholithiasis 
8 cases were females indicating the high prevalence of stone disease in 
females.3cases presented with benign stricture.2 had distal CBD stricture 
;among  which one underwent triple bypass and one underwent biliary 
bypass. One had a history of previous surgery and had a proximal CBD 
stricture and was referred to higher care centre as hepatic bypass could not 
be done in our set up.One patient was diagnosed to have choledochal cyst 
and was referred to higher centre for further management. 
             The most common malignant etiology appears to be periampullary 
carcinoma in my study.About 24% of the malignant etiology and 34% of the 
overall etiology of obstructive jaundice appears to be periampullary 
carcinoma.Among the 12 cases 5 were treated with triple bypass and rest 7 
were treated with palliative therapy. 
                The next most common malignancy appears to be carcinoma head 
of pancreas. Among the 7 cases 4 underwent triple bypass and 3 received 
palliative chemotherapy. Liver secondaries with porta hepatis  nodes was 
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found to be the cause in 6 cases accounting to 12%.Among them 2 had 
primary in the stomach and received palliative chemotherapy. One had 
primary in the breast and received palliative chemoradiotherapy. Rest 3 had 
unknown primary. They were treated with trucut biopsy and appropriate 
chemotherapy according to the histology. 
                   Among the 5 cases with cholangiocarcinoma 1 was treated with 
surgery.2 cases with duodenal carcinoma were treated with gastrointestinal 
bypass surgery. Other causes for malignant obstructive jaundice are Klatskin 
tumour and gall bladder carcinoma accounting to 4% and 2% respectively. 
INVESTIGATIONS: 
              Ultrasonography of abdomen was done in all cases. It revealed  
intrahepatic biliary radical (IHBR) dilatation in all  cases and CBD dilatation 
in 64% of cases.24 cases showed dilatation of both IHBR and CBD. Thus 
ultrasound has a high sensitivity in diagnosing the presence of obstruction to 
biliary tree and helps in confirmation of diagnosis. However results are 
operator dependant. Among the 35 cases with malignant disease USG was 
able to detect the growth in 14 cases and among the 15 cases with benign 
disease USG was able to detect the presence of stones in CBD in 3 cases. 
               According to Jennifer et al 
[2]
study US is the procedure of choice 
for the initial evaluation of cholestasis and for helping differentiate 
extrahepatic from intrahepatic causes of jaundice 
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                 Even Asma Afzal Kiani et al 
[6]
study stated that- Ultrasonography 
should be the first and best initial imaging procedure in patients who have 
obstructive jaundice. 
               CT Abomen with both plain and contrast was done in all cases. It 
was able to diagnose the presence of obstructive jaundice and etiology of 
obstruction to biliary tree in almost all cases. It was able to diagnose the 
presence of ascites in 10 cases and lymphadenopathy in 11 cases. Thus CT 
was found to be more sensitive and specific than USG. 
               According to Jennifer et al 
[2]
study - Traditional computed 
tomography (CT) scan is usually considered more accurate than US for 
helping determine the specific cause and level of obstruction. 
MORBIDITY AND MORTALITY DUE TO THE DISEASE: The important 
morbidity of the disease was found to be malignant cachexia found in 25 
among the 35 cases with malignant etiology. Ascites was present in about 
36% cases. Most of the cases with malignant cachexia had ascites. Most of 
them had controlled ascites .2 cases had uncontrolled ascites and underwent 
repeated tapping . 
                 The next most common morbidity is liver secondaries due to 
advanced malignancy.13 cases had this complication even at the time of 
presentation. Among them 6 cases had liver secondaries with porta hepatis 
nodes causing obstruction to biliary tree with primary elsewhere and rest had 
75 
 
primary in the biliary tree like periampullary region, head of pancreas and 
Klatskin tumour with liver secondaries occurring due to advancement of 
disease.The other morbidities are anorexia, gastric outlet obstruction and 
cholangitis. 
                 Mortality occurred in 3 cases. One with cholangiocarcinoma-
patient underwent triple bypass and patient expired post operatively. One 
with advanced carcinoma head of pancreas. Patient received palliative 
chemotherapy. One with metastatic carcinoma breast with liver secondaries 
and porta hepatis nodes. Patient received palliative chemoradiotherapy and 
patient expired. The mortality rate is 6% of the cases. 
             Abdul Ghafoor Dalwani et al 
[8]
study has showed a high mortality 
rate in about 11.25% of cases. 
TREATMENT: About 50% were treated with surgery indicating  the 
availability of surgical therapy for the disease. But many received only 
bypass procedures as surgical treatment due to the severity of the disease.11 
cases were treated with triple bypass; another  11 were  treated with CBD 
exploration and choledochoduodenostomy for stone disease;3 cases were 
treated with other types of bypass procedures for D2 duodenal carcinoma 
and biliary stricture. 
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              About 32% received palliative treatment like chemotherapy, 
radiotherapy and ascitic fluid tapping. Another 12% were referred to higher 
centre and 6% were non-compliant to treatment. 
SURGERY: 
               About 44% cases were treated with triple bypass for biliary 
drainage and gastrointestinal drainage.44%were treated with 
choledocholithotomy and choledochoduodenostomy for stone disease.12% 
were treated with other bypass procedures. 
TREATMENT COMPLICATIONS: 
             Most common complication was inoperability as most patients 
presented to our hospital with advanced malignancy like periampullary 
carcinoma, CA head of pancreas, cholangiocarcinoma, porta hepatis nodes 
and were given only palliative therapy. 
           16% presented with biliary gastritis post operatively and were treated 
with sucralfate syrup.8% had wound infection and were treated with culture 
,sensitivity and appropriate antibiotics. 
          48% were discharged with good general condition .13 cases which 
were operated  did not have any complications. 
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                S Verma et al study
[1]
 has stated that- Malignant obstructive 
jaundice is predominant in males compared to females. Benign obstruction is 
seen at a comparatively younger age group compared to malignant. 
             Syed Nizamuddin et al 
[5]
study showed that benign jaundice is 
prevalent in younger patients while malignant causes in elder age group and 
CT scan is important to diagnose the causative factor of obstructive jaundice. 
            Satish K. Bhargava et al 
[7]
study proved the same that Ultrasound 
was found to be the preliminary investigation of choice for the  diagnosis of 
the presence of obstruction and to some extent the level of obstruction. 
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CONCLUSION 
Obstructive jaundice was found to affect male population most 
commonly and most commonly elderly age group with 50-60 years being 
38% affected in my study. 
Malignancy  was found to most commonly affect elderly male 
patients. 
The most common complaint was found to be jaundice in about 
54%.Abdominal pain was the most common complaint  in benign stone 
disease which affected females more. 
The commonest etiology was found to be malignancy affecting about  
70% of cases .Periampullary carcinoma was the commonest malignancy 
accounting for 24% of the overall etiology. The most common benign 
etiology was choledocholithiasis with 73.3%  of the benign etiology. 
           Ultrasonography of the abdomen is very accurate in diagnosing the 
presence of obstruction to the biliary tree ,easily available and cost effective 
but operator dependant. 
CT Abdomen is reliable in confirming the diagnosis and determining 
the level of obstruction. In malignancies it gives information also about the 
operability of the tumour. 
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             The commonest morbidity is malignant cachexia and ascites. 
Mortality rate in my study is about 6% all with advanced malignancy even at 
the time of presentation. 
                  48% of the cases  did not have any treatment complications 
among which 13 cases were treated by surgery. Thus surgery is the best 
modality of treatment in all operable cases at the time of presentation and by 
pass procedures have less post -operative morbidity and mortality. 
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PROFORMA 
TIRUNELVELI MEDICAL COLLEGE  HOSPITAL . 
TIRUNELVELI-11. 
CASE RECORD. 
NAME:                                                    IP NUM: 
AGE/SEX: 
WARD:                                                   UNIT: 
ADDRESS: 
 
COMPLAINTS: 
HISTORY OF PRESENT ILLNESS: 
 
PAST HISTORY:                Diabetes        Hypertension 
                                           Chronic drug ingestion 
                                           Jaundice 
FAMILY HISTORY: 
PERSONAL HISTORY: 
GENERAL EXAMINATION: 
Vital signs:                                               Build: 
Pulse:                                                       Pallor: 
BP:                                                            Icterus: 
RR:                                                            Pedal edema: 
Lymph nodes: 
Musculoskeletal: 
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Scratch marks: 
Signs of liver cell failure: 
SYSTEMIC EXAMINATION: 
        ABDOMEN: 
        CVS: 
        RS: 
        CNS: 
Stage of CA (in case of malignancy): 
INVESTIGATIONS: 
BLOOD:1.Hb                                                         2.Sugar 
                  TC                                                            Urea 
                  DC                                                           Creatinine 
                  ESR                                                          Serum electrolytes 
3.Liver function tests: 
 
4.Blood grouping and typing: 
5.BT:                                                                           PT: 
   CT:                                                                           aPTT: 
 
URINE:1.Albumin:                                                2.Bile salts: 
                Sugar:                                                        Bile pigments: 
                Deposits:                                                   Urobilinogen: 
RADIOLOGY: 
        1.USG Abdomen: 
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        2.CT Abdomen: 
        3.MRCP: 
 
ASSESSMENT OF DISEASE SEVERITY: 
             CHILD PUGH CLASSIFICATION SCORE- 
             GRADE- 
 
PRE-OPERATIVE PREPARATION: 
 
TYPE OF SURGERY DONE: 
 
INTRA-OPERATIVE FINDINGS: 
 
POST OPERATIVE MANAGEMENT: 
 
EFFICACY OF USG AND CT: 
 
MORBIDITY AND MORTALITY DUE TO THE DISEASE: 
 
MORBIDITY AND MORTALITY  FOLLOWING SURGERY: 
  
   
Sl. No Name IP No Age Sex Complaint Cause Ultrasound Abdomen CT Abdomen Morbidity and Mortality Treatment Treatment Complication
1 TAMILSELVAN 37466 53 M JAUNDICE CBD STRICTURE
HEPATOMEGALY WITH CBD 
DILATATION
TERMINAL CBD STRICTURE PRURITIS,ANOREXIA TRIPLE BYPASS WOUND INFECTION
2 THANGAVADIVU 5633 65 F JAUNDICE
PERIAMPULLARY 
CARCINOMA
?PERIAMPULLARY GROWTH PERIAMPULLARY GROWTH ANOREXIA PATIENT NOT WILLING NON COMPLIANCE
3 CHELLAMMAL 61214 70 F JAUNDICE CHOLEDOCHOLITHIASIS CHOLEDOCHOECTASIA
CHOLEDOCHOLITHIASIS 15mm 
CALCULUS
VOMITING CHOLEDOCHODUODENOSTOMY UNEVENTFUL
4 POOLAMMAL 6963 60 F
ABDOMINAL PAIN 
AND DISTENSION
CA HEAD OF PANCREAS ?CA HEAD OF PANCREAS
CA HEAD OF PANCREAS WITH  
ASCITES
ASCITES
ASCITIC FLUID TAPPING TWICE 
DAILY,CHEMOTHERAPY
INOPERABILITY
5 VASANTHA 997 45 F ABDOMINAL PAIN
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR
?PERIAMPULLARY GROWTH WITH 
BILIARY TRACT DILATATION
CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
6 RAHUMATH BEEVI 7143 50 F ABDOMINAL PAIN
PERIAMPULLARY 
CARCINOMA
ASCITES,LIVER SECONDARIES
PERIAMPULLARY 
GROWTH,ASCITES,LIVER 
SECONDARIES
ASCITES,LIVER SECONDARIES
INOPERABLE-PALLIATIVE 
CHEMOTHERAPY
INOPERABILITY
7 VEMBU 11781 55 F
JAUNDICE,VOMITI
NG,ITCHING
CHOLEDOCHOLITHIASIS
CHOLELITHIASIS,CHOLEDOCHO
ECTASIA,HEPATIC STEATOSIS
CHOLELITHIASIS WITH 
CHOLEDOCHOLITHIASIS
PRURITIS,ANOREXIA
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
WOUND INFECTION
8 SUBBULAKSHMI 16510 39 F ABDOMINAL PAIN CHOLEDOCHOLITHIASIS
OBSTRUCTION IN BILIARY TREE 
DUE TO STONE IN DISTAL CBD
CHOLEDOCHOLITHIASIS,DILATATI
ON OF PROXIMALBILIARY 
SYSTEM,BILIARY HEPATITIS
CHOLANGITIS,BILIARY 
HEPATITIS
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
BILIARY GASTRITIS
9 SARASWATHY 10755 55 F
LOSS OF 
APPETITE,VOMITIN
G
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR
?PERIAMPULLARY GROWTH WITH 
BILIARY TRACT DILATATION
CACHEXIA TRIPLE BYPASS WOUND INFECTION
10
RAMASUBRAMANIA
N
15443 57 M
ABDOMINAL 
PAIN,VOMITING
D2 DUODENAL 
CARCINOMA
?PERIAMPULLARY GROWTH
DUODENAL GROWTH WITH 
GOO,MULTIPLE LIVER 
SECONDARIES
LIVER 
SECONDARIES,CACHEXIA
POSTERIOR 
GASTROJEJUNOSTOMY,CHOLECY
STECTOMY WITH 
CHOLEDOCHODUODENOSTOMY 
DONE 8MON BACK FOR 
CHOLEDOCHOLITHIASIS
BILIARY GASTRITIS
11 SHANMUGAVEL 18586 74 M JAUNDICE
DISTAL CBD 
CARCINOMA
GROWTH DISTAL CBD WITH 
IHBR DILATATION
?DISTAL CBD STRICTURE WITH 
GROWTH
MORTALITY TRIPLE BY-PASS PATIENT EXPIRED
12 SANTHA 70348 50 F JAUNDICE CA HEAD OF PANCREAS DILATED CBD AND IHBR
CA HEAD OF 
PANCREAS,ASCITES,LYMPHADEN
OPATHY
MORTALITY PALLIATIVE CHEMOTHERAPY PATIENT EXPIRED
13 AKBAR AZATH 58460 38 M
ABDOMINAL 
PAIN,JAUNDICE
CA STOMACH WITH 
LIVER SECONDARIES
LIVER 
SECONDARIES,ASCITES,PORTA 
HEPATIS NODES
ANTRAL WALL THICKENING,LIVER 
SECONDARIES,ASCITES,LYMPHAD
ENOPATHY
CACHEXIA CHEMOTHERAPY INOPERABILITY
14 KATHAR 30206 74 M JAUNDICE
PERIAMPULLARY 
CARCINOMA
DILATED IHBR,ASCITES
PERIAMPULLARY 
GROWTH,ASCITES,LIVER 
SECONDARIES,LYMPHADENOPAT
HY
CACHEXIA
ASCITIC FLUID TAPPING TWICE 
DAILY,CHEMOTHERAPY
INOPERABILITY
15 UTHIRAVASAGAM 37482 52 M JAUNDICE
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR PERIAMPULLARY GROWTH
LIVER 
SECONDARIES,CACHEXIA
TRIPLE BYPASS ADVANCEMENT OF GROWTH
16 SHANMUGAVEL 37578 60 M ABDOMINAL PAIN LIVER SECONDARIES
HEPATOMEGALY WITH LIVER 
SECONDARIES
LIVER SECONDARIES,PARA-
AORTIC 
LYMPHADENOPATHY,PORTA 
HEPATIS NODES
CACHEXIA
TRUCUT LIVER BIOPSY AND 
CHEMOTHERAPY
UNKNOWN PRIMARY
MASTER CHART
17 SORNAM 43195 70 M ABDOMINAL PAIN CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR 13mm TERMINAL CBD CALCULUS CHOLANGITIS
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
BILIARY GASTRITIS
18 PETCHIAMMAL 40448 45 F JAUNDICE KLATSKIN TUMOUR DILATED CBD AND IHBR KLATSKIN TUMOUR CACHEXIA REFFERED TO HIGHER CENTRE INOPERABILITY
19 KAJA MOHAIDEEN 44607 52 M JAUNDICE
CHOLANGIOCARCINOM
A
INCREASED PERIPORTAL 
ECHOGENICITY
DISTAL CBD GROWTH CACHEXIA AMA DISCHARGE NON COMPLIANCE
20 BHAGAVATHY 45979 45 F
ABDOMINAL 
PAIN,VOMITING
CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR
16mm CALCULUS IN TERMINAL 
CBD
ANOREXIA
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
BILIARY GASTRITIS
21 PETCHIAPPAN 46753 64 M JAUNDICE
CALCULOUS 
CHOLECYSTITIS WITH 
CBD STONES WITH 
SPLEENOMEGALY 
CALCULOUS CHOLECYSTITIS 
WITH SPLEENOMEGALY
CHOLELITHIASIS,10mm CBD 
STONE,SPLEENOMEGALY
PRURITIS
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY 
WITH SPLEENECTOMY
BILIARY GASTRITIS
22 MALIAMMAL 51364 50 F JAUNDICE KLATSKIN TUMOUR
DILATED CBD AND 
IHBR,MULTIPLE LIVER 
SECONDARIES
KLATSKIN TUMOUR,LIVER 
SECONDARIES
CACHEXIA REFERRED TO HIGHER CENTRE INOPERABILITY
23 GANAPATHY 59407 64 M
JAUNDICE,ABDOMI
NAL DISTENSION
CA HEAD OF PANCREAS
DILATED CBD AND 
IHBR,BILIARY STASIS
CA HEAD OF PANCREAS WITH  
ASCITES,IHBR AND CBD 
DILATATION
CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
24 PATHIRAPANDI 59487 57 M
ABDOMINAL 
DISTENSION
PROXIMAL CBD 
STRICTURE
DILATED CBD AND IHBR
PROXIMAL CBD 
STRICTURE,ASCITES
PRURITIS,ANOREXIA REFERRED TO HIGHER CENTRE INOPERABILITY
25 KOMBAN 53777 57 M JAUNDICE CA HEAD OF PANCREAS DILATED CBD GROWTH HEAD OF PANCREAS CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
26 MURUGAN 56455 45 M JAUNDICE
RECURRENT CA HEAD 
OF PANCREAS
PNEUMOBILIA
RECURRENT GROWTH HEAD AND 
BODY OF PANCREAS
ASCITES,LYMPHADENOPATHY CHEMOTHERAPY INOPERABILITY
27 MUTHAIAH 57873 50 M JAUNDICE
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR PERIAMPULLARY GROWTH CACHEXIA CHEMOTHERAPY NON COMPLIANCE
28 SIVAN 60400 58 M JAUNDICE
PERIAMPULLARY 
CARCINOMA
CHOLEDOCHOECTASIA
PERIAMPULLARY 
GROWTH,ASCITES,LIVER 
SECONDARIES
CACHEXIA CHEMOTHERAPY INOPERABILITY
29 RAJ 66680 52 M
ABDOMINAL 
PAIN,VOMITING
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR PERIAMPULLARY GROWTH PRURITIS,VOMITING TRIPLE BYPASS ADVANCEMENT OF GROWTH
30 AMUTHA 62703 23 F JAUNDICE CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR
CHOLEDOCHOLITHIASIS CAUSING 
OBSTRUCTION TO BILIARY TREE
VOMITING
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
UNEVENTFUL
31
BALASUBRAMANIA
N
15443 51 M VOMITING
D2 DUODENAL 
CARCINOMA
DILATED CBD AND IHBR
DUODENAL GROWTH WITH 
GOO,MULTIPLE LIVER 
SECONDARIES
GOO
PORTERIOR 
GASTROJEJUNOSTOMY,CHEMOT
HEAPY
BILIARY GASTRITIS
32 SUBBAMMAL 44318 60 F
ABDOMINAL 
PAIN,VOMITING
CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR 18mm DISTAL CBD CALCULUS PRURITIS,ANOREXIA,PAIN
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
BILIARY GASTRITIS
33 ESWARI 56557 30 F
ABDOMINAL 
PAIN,VOMITING
PERIAMPULLARY 
CARCINOMA
DILATED CBD DND IHBR PERIAMPULLARY GROWTH CACHEXIA CHEMOTHERAPY NON COMPLIANCE
34 PUSHPATHAI 63239 20 F
ABDOMINAL 
PAIN,VOMITING
CHOLEDOCHOLITHIASIS DILATED CBD DND IHBR
CHOLEDOCHOLITHIASIS,DILATATI
ON OF PROXIMALBILIARY SYSTEM
VOMITING
CHOLECYSTECTOMY WITH CBD 
EXPLORATION AND 
CHOLEDOCHODUODENOSTOMY
UNEVENTFUL
35 LAKSHMI 45555 35 F JAUNDICE CHOLEDOCHAL CYST DILATED CBD CHOLEDOCHAL CYST TYPE1 PRURITIS,ANOREXIA REFERRED TO HIGHER CENTRE INOPERABILITY
36 BASKRAN 26433 70 M JAUNDICE
 CARCINOMA PYLORUS 
WITH LIVER 
SECONDARIES
ASCITES,LIVER SECONDARIES
ANTRAL WALL THICKENING,LIVER 
SECONDARIES,PORTA HEPATIS 
NODES
CACHEXIA CHEMOTHERAPY INOPERABILITY
37 KANAGARAJ 57215 50 M JAUNDICE CA HEAD OF PANCREAS DILATED CBD AND IHBR GROWTH HEAD OF PANCREAS CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
38 RAMACHADRAN 47793 30 M JAUNDICE
CHOLANGIOCARCINOM
A
DILATED IHBR,ASCITES DISTAL CBD GROWTH CACHEXIA REFERRED TO HIGHER CENTRE INOPERABILITY
39 SUBBAIAH 43046 60 M
ABDOMINAL 
PAIN,VOMITING
LIVER SECONDARIES
DILATED IHBR,ASCITES,LIVER 
SECONDARIES
LVIER SECONDARIES,PORTA 
HEPATIS NODES
CACHEXIA
TRUCUT LIVER BIOPSY AND 
CHEMOTHERAPY
UNKNOWN PRIMARY
40 VADIVATHAL 60420 50 F
ABDOMINAL 
PAIN,VOMITING
PERIAMPULLARY 
CARCINOMA
DILATED IHBR,ASCITES
PERIAMPULLARY 
GROWTH,ASCITES,LIVER 
SECONDARIES
CACHEXIA CHEMOTHERAPY INOPERABILITY
41 JOSEPH 50419 38 M ABDOMINAL PAIN
CHOLANGIOCARCINOM
A
DILATED IHBR,ASCITES CHOLANGIOCARCINOMA CACHEXIA CHEMOTHERAPY INOPERABILITY
42 GANDHI 57071 65 M JAUNDICE,ITCHING
PERIAMPULLARY 
CARCINOMA
DILATED CBD AND IHBR PERIAMPULLARY GROWTH CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
43 THANGAPANDIAN 43017 56 M ABDOMINAL PAIN LIVER SECONDARIES
LARGE MULTIPLE 
SECONDARIES,PORTA HEPATIS 
NODES
LIVER SECONDARIES,PARA-
AORTIC 
LYMPHADENOPATHY,ASCITES
CACHEXIA
TRUCUT LIVER BIOPSY AND 
CHEMOTHERAPY
UNKNOWN PRIMARY
44 ALAGAPPAN 47207 55 M JAUNDICE DISTAL CBD STRICTURE DILATED CBD AND IHBR
DISTAL CBD STRICTURE,CALCIFIC 
PANCREATITIS
PRURITIS,ANOREXIA
PALLIATIVE BILIARY BYPASS-
CHOLECYSTOJEJUNOSTOMY 
WITH JEJUNOJEJUNOSTOMY
WOUND INFECTION
45 SUBBAIAH 53571 50 M ABDOMINAL PAIN
GALL BLDDER 
CARCINOMA
DILATED CBD AND IHBR GALL BLADDER GROWTH,ASCITES CACHEXIA REFERRED TO HIGHER CENTRE INOPERABILITY
46 KARUPPAYEE 64948 50 F JAUNDICE CA HEAD OF PANCREAS
DILATED IHBR,?UNDERLYING 
GROWTH
FOCAL CALCIFICATIONS IN HEAD 
OF PANCREAS
CACHEXIA TRIPLE BYPASS ADVANCEMENT OF GROWTH
47 SUBBULAKSHMI 48262 55 F JAUNDICE
METASTATIC 
CARCINOMA BREAST
LIVER SECONDARIES,ASCITES
LIVER SECONDARIES,IHBR  
DILATATION,PORTA HEPATIS 
NODES
MORTALITY
PALLIATIVE 
CHEMORADIOTHERAPY
PATIENT EXPIRED
48 PALAVESAM 18240 70 F ABDOMINAL PAIN DISTAL CBD GROWTH DISTAL CBD GROWTH
?CHOLANGIOCARCINOMA,BILIARY 
TRACT DILATATION
ASCITES AMA DISCHARGE NON COMPLIANCE
49 SAROJA 36029 55 F JAUNDICE CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR
CHOLELITHIASIS WITH DISTAL CBD 
STONES
PRURITIS
SUBTOTAL CHOLECYSTECTOMY 
WITH 
CHOLEDOCHODUODENOSTOMY
UNEVENTFUL
50 SANKARAN 64491 85 M ABDOMINAL PAIN CHOLEDOCHOLITHIASIS DILATED CBD AND IHBR
MULTIPLE CBD CALCULI,BILIARY 
ECTASIA
ANOREXIA,PAIN CHOLEDOCHODUODENOSTOMY BILIARY GASTRITIS
